Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection

Journal of Clinical Oncology

Volumn 23, Issue 25, 2005, Pages 6149-6156

  Beck, Stephen D W ^a   Foster, Richard S ^a   Bihrle, Richard ^a   Einhorn, Lawrence H ^a   Donohue, John P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN; IFOSFAMIDE; TUMOR MARKER; VINBLASTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FIBROSIS; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALIGNANT TERATOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SALVAGE THERAPY; BLOOD; COHORT ANALYSIS; LYMPHADENECTOMY; METASTASIS; NEOPLASM; PATHOLOGY; PATIENT CARE PLANNING; PREDICTION AND FORECASTING; RETROPERITONEUM; SURVIVAL; TREATMENT OUTCOME;

ALPHA-FETOPROTEINS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COHORT STUDIES; HUMANS; LYMPH NODE EXCISION; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PATIENT CARE PLANNING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROPERITONEAL SPACE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 24944559731     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.11.684     Document Type: Article

References (9)

1. Eastham JA, Wilson TG, Russell C, et al: Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. Urology 43:74-80, 1994
2. Coogan CL, Foster RS, Rowland RG, et al: Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone. Urology 50:957-962, 1997
3. Albers P, Ganz A, Hannig E, et al: Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 164:381-384, 2000
4. Murphy BR, Breeden ES, Donohue JP, et al: Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 11:324-329, 1993
5. Ravi R, Ong J, Oliver RT, et al: Surgery as salvage therapy in chemotherapy-resistant non-seminomatous germ cell tumours. Br J Urol 81:884-888, 1998
6. Wood DP Jr, Herr HW, Motzer RJ, et al: Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers. Cancer 70:2354-2357, 1992
7. van der Gaast A, Hoekstra JW, Croles JJ, et al: Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma. J Urol 145:829-831, 1991
8. Donohue JP, Leviovitch I, Foster RS, et al: Integration of surgery and systemic therapy: Results and principles of integration. Semin Urol Oncol 16:65-71, 1998
9. Fox EP, Weathers TD, Williams SD, et al: Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 11:1294-1299, 1993